2002
DOI: 10.1016/s0168-3659(01)00498-9
|View full text |Cite
|
Sign up to set email alerts
|

Enhanced bone formation by controlled growth factor delivery from chitosan-based biomaterials

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

2
144
1
2

Year Published

2004
2004
2024
2024

Publication Types

Select...
5
5

Relationship

0
10

Authors

Journals

citations
Cited by 278 publications
(149 citation statements)
references
References 42 publications
2
144
1
2
Order By: Relevance
“…Owing to the rapid advances in recombinant technology and the availability of large scale manufacturing of cytokines and growth factors, many recent tissue engineering strategies have turned to the use of specific growth factors to stimulate cellular activity in vitro and for improved functional neotissue formation in vivo [2][3][4][5]. Importantly, the delivery mode appears to be critical for the application of these factors in tissue engineering [6][7][8].…”
Section: Introductionmentioning
confidence: 99%
“…Owing to the rapid advances in recombinant technology and the availability of large scale manufacturing of cytokines and growth factors, many recent tissue engineering strategies have turned to the use of specific growth factors to stimulate cellular activity in vitro and for improved functional neotissue formation in vivo [2][3][4][5]. Importantly, the delivery mode appears to be critical for the application of these factors in tissue engineering [6][7][8].…”
Section: Introductionmentioning
confidence: 99%
“…Modification of poly-(lactic acid) devices that release bone morpho genetic protein 2 (BMP2) 83 and chitosan enhanced bone regeneration due to an increase in cell adhesion to the polymer matrix. Furthermore, coupling oligopeptides that contain the RGD sequence to protein delivery vehicles may also improve the cellular response to growth factors by facilitating cell migration into the material, activating the cells to the desired responsive state and subsequently exposing the cells to the drug in a controlled manner 84 .…”
Section: Antisense Therapymentioning
confidence: 99%
“…The physical properties of a polymer can be altered by introducing a second polymer that improves the properties of the original polymer in certain aspects, such as hydrophobility, cell compatibility. CS and some of its complexes have been studied for a number of biomedical applications, including wound dressings, drug delivery systems and space-filling implants [12][13][14][15][16][17][18]. In a study comparing purified collagen, naturally occurring extracellular matrix (ECM) scaffolds, and synthetic scaffold materials for in vitro endothelial cell attachment [19], it was found that ECM possessed the ability to recruit circulating marrow-derived progenitor cells and attract mature endothelial cells from selected organs such as the heart and liver to promote successful vascularization of engineered tissue structures.…”
Section: Introductionmentioning
confidence: 99%